FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Articles

How AI and Digital Innovation Are Transforming the Future of the FinTech Industry

Admin Aug 11, 2026 0
Whitepaper

The Power of Ecosystems for Banking

Articles

The Rise of Fintech: Transforming the Financial Landscape

Articles

Why Financial Services and Banks Need an Operational Data Layer

Articles

FinTech Futures: How Media, Advertising & Marketing Are Shaping…

Articles

Will fintech impact daily life in Asia and Africa?

Admin Apr 15, 2026
The contemporary world is ever-evolving and provides society with more resources than in the past. Millions of…
Featured News

Fintech Innovation Accelerates in 2026 as Digital Payments and AI Redefine…

Admin Apr 14, 2026
The fintech industry is witnessing rapid evolution in 2026, driven by the growing adoption of digital payments,…
Featured News

US Dollar vs Indian Rupee in 2026: Currency Pressure Continues to Shape India’s…

Admin Apr 13, 2026
In 2026, the ongoing battle between the US Dollar and the Indian Rupee remains a key focus for economists,…
Upcoming conference

The Future of Finance: Navigating Innovation, Risk, and Global Growth

Admin Apr 10, 2026
The global finance industry is gearing up for a dynamic year ahead, with several high-impact conferences set to…
Whitepaper

DRIVING SALESFORCE FINANCIAL SERVICE CLOUD ADOPTION IN BANKS

Admin Apr 9, 2026
While it may seem like common sense alone would influence end users to adopt the superior FSC tools that you are…
Featured News

Through a new partnership, Glia’s digital interaction solutions are now…

Admin Apr 8, 2026
In order to simplify digital-first member service, Glia, the leader in customer interactions that unifies…
Whitepaper

Life After QuickBooks: Why It’s Time to Step Up to Sage Intacct for Business-Class…

Admin Apr 7, 2026
For many small and mid-sized businesses, Intuit QuickBooks is the preferred choice for financial software in the…
Articles

Fintech Revolution 2026: AI, Stablecoins, and Global Expansion Reshape Financial…

Admin Apr 6, 2026
The global fintech industry in 2026 is witnessing a powerful transformation driven by artificial intelligence,…
Articles

The Role of Finance Management Software in Corporate Organizations

Admin Apr 2, 2026
Finance management software has become indispensable in corporate organizations, revolutionizing the way…
Featured News

Rupee vs Dollar Debate Intensifies: Economic Reality or Political Narrative?

Admin Apr 1, 2026
A fresh wave of debate has erupted across India’s financial and political landscape over the long-standing…
Whitepaper

FinTechnicolor: The New Picture in Finance

Admin Mar 31, 2026
Banking has historically been one of the business sectors most resistant to disruption by technology. Since the…
Articles

Capital Markets: The Significance of Today’s Advance for the Aussie and…

Admin Mar 30, 2026
Global capital markets are experiencing a notable shift as both the Australian dollar (Aussie) and the British…
Whitepaper

The Power of Ecosystems for Banking

Admin Mar 25, 2026
Banking is being changed from within as the Banking-as-a-Serivce (BaaS) model and real-time payments (RTP) take…
Featured News

LPG Cylinder Crisis in India 2026: Rising Costs and Supply Disruptions Shake…

Admin Mar 23, 2026
India is currently witnessing a significant LPG (cooking gas) crisis in 2026, which is having a direct and…
Articles

FinTech Sector Empowerment Through Drupal Distributions & Modules

Admin Mar 19, 2026
The FinTech industry is undergoing rapid digital transformation driven by technologies like AI, cloud…
Articles

Insurers Can Learn From Banks: How to Convert Data Into Profits

Admin Mar 18, 2026
In today’s data-driven economy, financial institutions are sitting on a goldmine of untapped potential. While both…
Featured News

AI Adoption Expected to Transform India’s Economy and Job Market

Admin Mar 17, 2026
The growing integration of artificial intelligence into business operations is also reshaping the Indian job…
Featured News

Rising LPG Prices and Supply Concerns Put Pressure on India’s Economy

Admin Mar 16, 2026
India’s cooking gas sector is witnessing renewed attention as rising global energy prices and geopolitical…
Whitepaper

Financing Social Good – What the RBC Social Finance Initiative Has Taught Us

Admin Mar 13, 2026
Invest in for-profit businesses with a social or environmental purpose through the $10 million RBC Generator .…
Whitepaper

Climate-Related Financial Risk

Admin Mar 12, 2026
Climate-related financial risk has become a prominent theme that is high on the agenda of U.S. and European…
Articles

Where to Look for Simple Loans for Businesses

Admin Mar 11, 2026
It is now simpler than ever to obtain a small company loan. There are business loans with quick approval processes…
Articles

Does deposit insurance impede the growth of financial markets that are not banks?

Admin Mar 10, 2026
Depending on whether banks and non-bank financial markets are complementary or replacements, and on whether theory…
Articles

Traders with High Frequency: Experts in Contemporary Financial Markets

Admin Mar 9, 2026
High Frequency Traders (HFT) operate in a high-speed environment, aiming to capture small profits through…
Articles

Bloomberg Introduces New Financial Instrument Global Identifier (FIGI) Mapping…

Admin Mar 6, 2026
In order to give exchanges, data providers, custodians, and other organizations direct access to a variety of…
Whitepaper

For the Capital Markets, Every Risk Playbook Needs to Implement These 6 Themes

Admin Mar 5, 2026
The capital markets have not really benefitted from any tailwinds recently: Inflation rose and is not yet close to…
Whitepaper

Understanding the Financial Interest Clause

Admin Mar 4, 2026
A Financial Interest Clause (FIC) is one of many options available to companies with multinational exposures. Like…
Whitepaper

Why financial institutions need one-to-one messaging to build profitable customer…

Admin Mar 3, 2026
By taking advantage of today’s technologically advanced world, there are many opportunities for financial…
Whitepaper

Challenges and opportunities of the metaverse in financial services

Admin Mar 2, 2026
Experts agree that the metaverse, from both a technological and a business perspective, still has a long way to go…
Articles

Software for Financial Accounting for Effective Management

Admin Feb 27, 2026
One kind of software that assists companies in managing their financial operations is financial accounting…
Featured News

Verifying B2B Payments with E-Invoicing: A Way to Ensure Long-Term Development

Admin Feb 26, 2026
For companies of all sizes and in all sectors, the use of electronic invoicing and payments, or "e-invoicing," is…
Articles

How to Establish a Brand with Social Media for Financial Advisors

Admin Feb 25, 2026
Establishing a strong brand presence on social media is essential for financial advisors looking to stand out…
Articles

The Fintech Industry’s Most Valuable Applications of Blockchain

Admin Feb 24, 2026
The decentralized network, protected data, transparent database, and encrypted transactions of blockchain…
Previous 1 2 3 4 5 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • How AI and Digital Innovation Are Transforming the Future of the FinTech Industry
    • The Power of Ecosystems for Banking
    • The Rise of Fintech: Transforming the Financial Landscape
    • Why Financial Services and Banks Need an Operational Data Layer
    • FinTech Futures: How Media, Advertising & Marketing Are Shaping the Next Generation of Financial Services

    ARTICLE

    Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
    2026-08-12T11:30:00Z
    Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2


    BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
    2026-08-12T11:30:00Z
    Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025


    PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
    2026-08-12T11:30:00Z
    FDA Accepted D-PLEX₁₀₀ NDA with Priority Review; PDUFA Goal Date of November 28, 2026, Approximately One Quarter Ahead of Previously Communicated Guidance


    Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
    2026-08-12T11:30:00Z
    Randomized Phase 2 trial in microsatellite stable colorectal cancer (MSS CRC) ongoing, with results expected in 1H 2027; potential registration trial expected in 2027 once recommended dose regimen has been...


    Altimmune Announces Second Quarter 2026 Financial Results and Business Update
    2026-08-12T11:30:00Z
    Initiated global PERFORMA Phase 3 trial in MASH


    Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:30:00Z
    Maintained strong financial position with cash, cash equivalents and marketable securities of $92.6M as of June 30, 2026


    Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality
    2026-08-12T11:12:02Z
    COPENHAGEN, Denmark, August 12, 2026 – Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the texture, firmness...


    Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:08:47Z
    Over 50% of commercially insured lives in the U.S., representing a recent and significant increase, now have coverage for CARDAMYST® (etripamil) nasal spray


    Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
    2026-08-12T11:05:00Z
    – Newly granted patent extends protection for ATH434 to at least 2045, significantly enhancing its strategic value and long-term commercial potential –


    Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance
    2026-08-12T11:05:00Z
    REHOVOT, Israel and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare...


    TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
    2026-08-12T11:00:00Z
    First patient dosed in Phase 3 ALLOHA-2™ study; topline readout expected mid-2028


    Kamada Announces Planned Transition of Chief Financial Officer
    2026-08-12T11:00:00Z
    REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare...


    Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
    2026-08-12T11:00:00Z
    NEWTON, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta...


    Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
    2026-08-12T11:00:00Z
    Finalized SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 in support of accelerated approval pathway; topline data expected in second half of 2027


    Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-12T11:00:00Z
    – Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with...


    Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
    2026-08-12T11:00:00Z
    NAPLES, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that...


    Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
    2026-08-12T11:00:00Z
    BROOMFIELD, Colo., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms...


    Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
    2026-08-12T11:00:00Z
    Namodenoson Holds FDA Fast Track and U.S. and European Orphan Drug Designations; Piclidenoson and Namodenoson Are Advancing in Phase III Programs


    Persephone Biosciences Publishes Largest U.S. Clinical Study of an Infant Synbiotic in Pediatric Research, Expanding Clinical Evidence for Its Infant Synbiotics
    2026-08-12T11:00:00Z
    Publication reports results from the largest U.S. randomized trial evaluating a synergistic Bifidobacterium-HMO synbiotic in infants and toddlers, demonstrating safety, successful gut colonization and biologically meaningful microbiome changes.


    LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
    2026-08-12T11:00:00Z
    On Track to Complete Enrollment of the Phase 3 ELAINE-3 clinical trial in 4Q 2026 with Topline Data Expected in 2H 2027


    Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
    2026-08-12T11:00:00Z
    – Encouraging early clinical activity including confirmed and ongoing unconfirmed partial responses with favorable tolerability, and pharmacokinetics (PK) observed in ongoing STRO-004 Phase 1 study –


    Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update
    2026-08-12T10:50:00Z
    ZUG, Switzerland, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living...


    Annexon Reports Second Quarter 2026 Financial Results, Business Updates and Key Anticipated Milestones
    2026-08-12T10:05:00Z
    Rapid, Positive Clinical Outcomes in GBS FORWARD Study Reinforce Consistency and Reproducibility of Tanruprubart Treatment Effect Demonstrated in Phase 3 and Real-World Evidence Studies; BLA Submission Expected in Q4 2026


    Annexon Expands Vonaprument Phase 3 Program in Geographic Atrophy with Addition of Month 24 Dual Primary Endpoint Complementing Month 15 Primary Endpoint and Launch of Open-Label Extension Study
    2026-08-12T10:00:00Z
    BRISBANE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies for multiple neuroinflammatory diseases that impact nearly...


    Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
    2026-08-12T09:00:00Z
    COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases https://doi.org/10.1093/cid/ciag446 describing the use of SNIPR001 in...


    Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
    2026-08-12T08:00:00Z
    Expanded financing broadens Rakovina’s strategic investor base and reinforces confidence in its AI-powered oncology platform


    BioPorto A/S to host an investor webcast on the results for the first half of 2026 
    2026-08-12T07:29:49Z


    FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
    2026-08-12T01:10:17Z
    FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares


    Silexion Therapeutics Announces Pricing of $2.5 Million Public Offering
    2026-08-12T00:01:00Z
    GRAND CAYMAN, Cayman Islands, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for...


    Anteris Technologies Announces Results for the Second Quarter of 2026
    2026-08-11T23:00:00Z
    MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, developing,...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.